Le Lézard
Classified in: Science and technology, Business

Taylor Morrison Extends Partnership with Constellation HomeBuilder Systems Enabling Rapid Growth


MARKHAM, Ontario, Jan. 14, 2019 /PRNewswire-PRWeb/ -- Constellation HomeBuilder Systems is proud to partner with one of the largest home building companies in North America, Taylor Morrison. Founded in 2007, Taylor Morrison has reached #6 on the Builder100 list with over 8,000 closings in 2017.

To meet its national growth projections, Taylor Morrison has trusted NEWSTAR Enterprise from Constellation HomeBuilder Systems to manage their home building operations as a system of record for all business activity.

Taylor Morrison has already begun using NEWSTAR Enterprise builder management software to unite their teams and strengthen the relationship between various business functions. As part of the partnership, Constellation HomeBuilder Systems will enable Taylor Morrison to grow and reach more markets than ever before. "Using NEWSTAR Enterprise and training our employees is the best way for us to grow," says John Lucas, Vice President of IT at Taylor Morrison. "As we move forward in this partnership, we're confident that Constellation will provide the support and expertise to help us manage significant growth."

Constellation HomeBuilder Systems constantly evolves their products based on the needs of public and private builders, and the industry in general. The company actively sponsors user groups and hosts industry events across North America to encourage face-to-face networking with other top builders, often swapping best practices and influencing upcoming product enhancements. "We are thrilled to continue working with a company like Taylor Morrison. This partnership reiterates our strong commitment to builders across North America," says Chris Graham, Vice President at Constellation HomeBuilder Systems. "We've been working closely together with Taylor Morrison for many years. We look forward to a very successful long-term partnership."

About Constellation HomeBuilder Systems
Constellation HomeBuilder Systems is the largest provider of software and services in the building industry. Their innovative software solutions, available as standalone or integrated systems, empower builders with information to drive business objectives and simplify the process of building homes and condos. Constellation HomeBuilder Systems is the home building software division of Constellation Software Inc., an international provider of market-leading software and services for specialized industries, which is traded publicly on the Toronto Stock Exchange.

 

SOURCE Constellation HomeBuilder Systems


These press releases may also interest you

at 08:05
Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the enrollment of the first patient in a pilot study collecting patient-generated health data (PGHD) during proton radiotherapy for lung cancer in...

at 08:05
AVI Systems, the largest global audiovisual and unified collaboration systems integrator, today announced the launch of a new customer-focused offering called the AVI Experience. This initiative provides prospects and customers interested in...

at 08:05
Elite Robots, a leading supplier of collaborative robots, will exhibit its enriched range of cobots and all-in-one solutions at the upcoming Automate Show (May 6-9, Chicago), at booth 4255. After a successful 2023, in which Elite Robots experienced...

at 08:05
Edgio, the platform of choice for security, speed and simplicity at the edge, today announced the release of its Client-Side Protection solution. Designed to monitor scripts and APIs on the browser-side to prevent malicious code from exfiltrating...

at 08:05
Today, Stellar Cyber, the innovator of Open XDR, announced a new partnership with Acronis, a global leader in cybersecurity and data protection, to deliver an optimized threat detection and response solution enabling MSPs to protect on-premises,...

at 08:05
Roivant and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and autoimmune diseases, today announced the successful completion of enrollment in its Phase 2 study evaluating namilumab for...



News published on and distributed by: